Mobile

A study to assess the efficacy and safety of tocilizumab versus placebo in patients with Systemic Sclerosis

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000424-28

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of tocilizumab (TCZ) compared with placebo on skin sclerosis, as measured by modified Rodnan Skin Score (mRSS) at Week 48

Critère d'inclusion

  • Systemic Sclerosis

Liens